Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20806
Title: Carotid artery stenting: Current state of evidence and future directions.
Authors: Lamanna, Anthony;Maingard, Julian;Barras, Christen D;Kok, Hong Kuan;Handelman, Guy;Chandra, Ronil V;Thijs, Vincent N;Brooks, Duncan Mark;Asadi, Hamed
Affiliation: Department of Radiology, Royal Victoria Hospital, Belfast, UK..
Interventional Radiology Service, Northern Hospital Radiology, Melbourne, Victoria, Australia
South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
The University of Adelaide, Adelaide, South Australia, Australia
Education and Research Centre, Beaumont Hospital, Dublin, Ireland
Interventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australia
Department of Imaging, Monash Health, Melbourne, Victoria, Australia
Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia
Interventional Neuroradiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
Stroke Division, The Florey Institute of Neuroscience & Mental Health, University of Melbourne, Melbourne, Victoria, Australia
The University of Melbourne, Melbourne, Victoria, Australia
Department of Neurology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Apr-2019
EDate: 2019-04
Citation: Acta neurologica Scandinavica 2019;139(4):318-333
Abstract: Both carotid endarterectomy (CEA) and carotid artery stenting (CAS) are common treatments for carotid artery stenosis. Several randomized controlled trials (RCTs) have compared CEA to CAS in the treatment of carotid artery stenosis. These studies have suggested that CAS is more strongly associated with periprocedural stroke; however, CEA is more strongly associated with myocardial infarction. Published long-term outcomes report that CAS and CEA are similar. A reduction in complications associated with CAS has also been demonstrated over time. The symptomatic status of the patient and history of previous CEA or cervical radiotherapy are significant factors when deciding between CEA or CAS. Numerous carotid artery stents are available, varying in material, shape and design but with minimal evidence comparing stent types. The role of cerebral protection devices is unclear. Dual antiplatelet therapy is typically prescribed to prevent in-stent thrombosis, and however, evidence comparing periprocedural and postprocedural antiplatelet therapy is scarce, resulting in inconsistent guidelines. Several RCTs are underway that will aim to clarify some of these uncertainties. In this review, we summarize the development of varying techniques of CAS and studies comparing CAS to CEA as treatment options for carotid artery stenosis.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20806
DOI: 10.1111/ane.13062
ORCID: 0000-0003-0705-2252
0000-0001-8958-2411
0000-0002-6614-8417
PubMed URL: 30613950
Type: Journal Article
Review
Subjects: carotid artery atherosclerosis
carotid artery stenosis
carotid artery stenting
carotid endarterectomy
stroke
stroke prevention
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.